Close Menu
Business Voice NowBusiness Voice Now
    Facebook X (Twitter) Instagram
    Business Voice NowBusiness Voice Now
    Subscribe
    • Markets
      • IPO
      • Market News
    • Business
      • FMCG
      • Retail
      • Quick Commerce
      • Startups
    • Healthcare
    • Technology
    • Energy
    • Voices
      • Entrepreneur – CXO Stories
      • Corporate Office story
    • E Magazine
      • Year 2026
        • October 2026
        • September 2026
        • August 2026
        • July 2026
    Business Voice NowBusiness Voice Now
    Home»Business»Thermo Fisher Scientific to Manufacture Nucleic Acid Isolation Kits In India
    Business

    Thermo Fisher Scientific to Manufacture Nucleic Acid Isolation Kits In India

    By September 28, 2021No Comments3 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Email
    Follow Us
    Google News Flipboard Threads
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Applied Biosystems MagMax Dx Prefilled Viral/Pathogen Nucleic Acid Isolation Kit isolates and purifies viral RNA and DNA from human saliva, nasopharyngeal and oropharyngeal swabs

    Mumbai (Maharashtra) [India], September 28: Thermo Fisher Scientific, the world leader in serving science, today announced that it will manufacture its Applied Biosystems MagMAX Dx Prefilled Viral/Pathogen Nucleic Acid Isolation Kits in India for the Indian market. The kit is used to isolate and purify viral RNA and DNA from human saliva, nasopharyngeal and oropharyngeal swabs, providing a faster, more precise and easier-to-use solution for customers.

    The MagMax Dx Prefilled Viral/Pathogen Nucleic Acid Isolation Kit will be manufactured in Thermo Fisher’s state-of-the-art manufacturing facility in Bengaluru. The site is currently used to produce CoviPath RT-PCR COVID-19 testing kits for customers in India.

    The isolation kit is designed for use by qualified and trained clinical laboratory personnel. It has been approved for in vitro diagnostic use by the Indian Council for Medical Research (ICMR) and the Drug Control General of India (DCGI).

    “Thermo Fisher Scientific has played a pivotal role in the global response against COVID-19, and we have made significant investments to support our customers in India,” said Amit Chopra, managing director, India and South Asia, Thermo Fisher Scientific. “While the situation is gradually improving, the world still needs more advanced solutions that improve testing quality and sustain bulk testing with less processing time, and the MagMAX Dx Prefilled Viral/Pathogen Nucleic Acid Isolation Kit will support this effort,” added Amit.

    The isolation kit enables highly scalable, accessible, faster and more consistent viral RNA and DNA extraction and can process up to 96 samples in 30 minutes. It comes with pre-filled, automation-ready media plates that can be used with Kingfisher Flex instruments with special automation-ready compatibility with the Thermo Scientific Kingfisher Flex Purification System.

    About Thermo Fisher Scientific 

    Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $35 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them. Our global team of more than 90,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon. For more information, please visit www.thermofisher.com.

    Contact Information:

    Mihir Deshpande

    Thermo Fisher Scientific

    022-66803040 mihir.deshpande@thermofisher.com

     

    Business
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    Varvee Global swings back to profitability, reports Rs 6.78 crore profit in Q2

    October 24, 2026

    Patel Retail Limited Enters Nashik District with New Store at Ghoti; Expands Presence to Four Districts

    October 24, 2026

    Forcas Studio Reports H1 FY27 Performance with Total Income of Rs 1,310.17 Mn & PAT of Rs 99.91 Mn

    October 24, 2026

    Comments are closed.

    Recent Post
    • Eight Parul University Researchers Recognised Among the World’s Top 2% Scientists in Stanford-Elsevier Rankings 2026
    • COLORFUL Launches iGame X870E ULTRA-S V14 Motherboard in India
    • Varvee Global swings back to profitability, reports Rs 6.78 crore profit in Q2
    • Tamil Film Dorothy Heads to Netflix in 5 Languages
    • Patel Retail Limited Enters Nashik District with New Store at Ghoti; Expands Presence to Four Districts
    • Forcas Studio Reports H1 FY27 Performance with Total Income of Rs 1,310.17 Mn & PAT of Rs 99.91 Mn
    • Australian clean energy delegation explores commercial partnerships with India at REI Expo 2026
    • Yaduvanshi Deepak Launched Money Is Oxygen at ICA Conclave 2026

    Type above and press Enter to search. Press Esc to cancel.